With 50 million residents and high per capita spending on healthcare, South Korea is one of the largest Asian healthcare markets, roughly equal in size...
In Brief: Brazil’s ANVISA Recognizes Second MDSAP Auditor
|
Brazilian medical device market regulator ANVISA has named a second firm, TÜV SÜD America, as an accredited audit organization under the international Medical Device Single Audit Program (MDSAP).
ANVISA has already recognized BSI as an accredited auditor under MDSAP. Now, both BSI and TÜV SÜD America may conduct audits in accordance with Brazilian regulators’ MDSAP implementation program.
The TÜV SÜD America recognition is valid until December 31, 2016, after which ANVISA may revoke or renew the MDSAP auditor accreditation.